U.S. Physical Therapy, Inc. (NYSE:USPH) Holdings Cut by EULAV Asset Management

EULAV Asset Management cut its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 41.2% in the 4th quarter, Holdings Channel reports. The firm owned 25,700 shares of the company’s stock after selling 18,000 shares during the quarter. EULAV Asset Management’s holdings in U.S. Physical Therapy were worth $2,280,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. The Manufacturers Life Insurance Company grew its position in U.S. Physical Therapy by 4.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock worth $670,000 after purchasing an additional 309 shares during the last quarter. Truist Financial Corp boosted its position in shares of U.S. Physical Therapy by 9.2% during the second quarter. Truist Financial Corp now owns 10,382 shares of the company’s stock worth $960,000 after buying an additional 874 shares during the period. Handelsbanken Fonder AB grew its holdings in U.S. Physical Therapy by 25.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 3,000 shares of the company’s stock worth $254,000 after buying an additional 600 shares in the last quarter. Martin Capital Advisors LLP increased its position in U.S. Physical Therapy by 1.6% in the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after acquiring an additional 201 shares during the period. Finally, Creative Planning bought a new stake in U.S. Physical Therapy during the 3rd quarter valued at $252,000.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $86.97 on Friday. The company has a 50-day moving average of $91.29 and a 200-day moving average of $88.51. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 92.52, a price-to-earnings-growth ratio of 3.61 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 2,000 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total transaction of $185,900.00. Following the sale, the director now owns 16,726 shares in the company, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.